Analysts are pricing in a 7% drop in revenue next year. Napkin math suggests that number makes sense 25% drop in sales of humira offset by gains elsewhere (Skyrizi and Rinvoq).
People have been talking about the patent cliff for 5+ years now. The news is ancient
iamfar_ t1_j69tp21 wrote
Reply to comment by Trash_Panda-1 in Abbvie to lose most lucrative patent protection one week before Q4 earnings call. by [deleted]
Analysts are pricing in a 7% drop in revenue next year. Napkin math suggests that number makes sense 25% drop in sales of humira offset by gains elsewhere (Skyrizi and Rinvoq).
People have been talking about the patent cliff for 5+ years now. The news is ancient